FASIHA KANWAL to Administration, Oral
This is a "connection" page, showing publications FASIHA KANWAL has written about Administration, Oral.
Connection Strength
0.418
-
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review. Gastroenterology. 2019 06; 156(8):2149-2157.
Score: 0.136
-
Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals. Hepatology. 2016 11; 64(5):1442-1450.
Score: 0.112
-
The end of hepatitis C. Clin Gastroenterol Hepatol. 2014 Apr; 12(4):533-6.
Score: 0.095
-
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA. Aliment Pharmacol Ther. 2018 Apr; 47(7):1023-1031.
Score: 0.031
-
Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):115-122.e10.
Score: 0.030
-
The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):988-997.
Score: 0.014